VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 188 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $993,202 | -1.5% | 235,356 | +0.8% | 0.03% | -6.9% |
| Q3 2023 | $1,008,556 | +144.8% | 233,462 | +318.8% | 0.03% | +141.7% |
| Q4 2022 | $411,985 | -15.4% | 55,749 | +24.8% | 0.01% | -14.3% |
| Q2 2022 | $487,000 | -2.6% | 44,657 | +0.9% | 0.01% | +40.0% |
| Q1 2022 | $500,000 | -33.9% | 44,250 | +25.8% | 0.01% | -58.3% |
| Q2 2021 | $757,000 | +56.7% | 35,187 | +9.3% | 0.02% | +33.3% |
| Q1 2021 | $483,000 | -35.5% | 32,184 | -43.5% | 0.02% | -48.6% |
| Q4 2020 | $749,000 | +50.7% | 56,996 | +10.8% | 0.04% | +25.0% |
| Q3 2020 | $497,000 | +168.6% | 51,452 | +217.9% | 0.03% | -9.7% |
| Q2 2020 | $185,000 | – | 16,184 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |